The Journal of Clinical Endocrinology & Metabolism,
Journal Year:
2023,
Volume and Issue:
109(1), P. e58 - e68
Published: Aug. 22, 2023
Skeletal
fragility
is
observed
in
30%
to
60%
of
acromegaly
patients,
representing
an
emerging
complication
the
disease
that
increases
disability.
Despite
several
studies
having
investigated
clinical
and
hormonal
prognostic
factors
for
occurrence
vertebral
fractures
(VFs)
acromegaly,
very
few
data
are
available
on
their
prevention/treatment
including
effect
vitamin
D
(VD)
supplementation,
which
has
been
reported
have
a
fracture-protective
patients
with
osteoporosis.We
aimed
investigate
role
cholecalciferol
(D3)
supplementation
prevention
incident
VFs
(i-VFs)
acromegaly.A
longitudinal,
retrospective
multicenter
study
was
performed
61
treated
untreated
D3
supplementation.Twenty-six
were
according
guidelines.
The
median
weekly
dosage
8500
IU
(interquartile
range
[IQR]:
3900).
duration
94
months
(IQR:
38).
At
last
follow-up,
i-VFs
diagnosed
14
(23%).
I-VFs
less
prevalent
(14.3%
cases)
compared
not
(85.7%;
P
=
.02).
final
level
serum
V25OH-D
significantly
lower
who
developed
(28.6
ng/mL,
IQR:
4.1)
did
develop
(34.2
9.6;
.05).
logistic
regression
confirmed
protective
(odds
ratio:
0.16;
95%
CI,
0.03-0.79;
.01).It
likely
could
lead
reduction
acromegaly.
Nutrients,
Journal Year:
2022,
Volume and Issue:
14(7), P. 1483 - 1483
Published: April 2, 2022
Vitamin
D
deficiency
has
a
high
worldwide
prevalence,
but
actions
to
improve
this
public
health
problem
are
challenged
by
the
heterogeneity
of
nutritional
and
clinical
vitamin
guidelines,
with
respect
diagnosis
treatment
deficiency.
We
aimed
address
issue
providing
respective
recommendations
for
adults,
developed
European
expert
panel,
using
Delphi
method
reach
consensus.
Increasing
awareness
efforts
harmonize
guidelines
should
be
pursued.
argue
against
general
screening
suggest
25-hydroxyvitamin
(25(OH)D)
testing
in
certain
risk
groups.
recommend
supplementation
dose
800
2000
international
units
(IU)
per
day
adults
who
want
ensure
sufficient
status.
These
doses
also
recommended
deficiency,
higher
(e.g.,
6000
IU
day)
may
used
first
4
12
weeks
if
rapid
correction
is
clinically
indicated
before
continuing,
maintenance
day.
Treatment
success
evaluated
after
at
least
6
groups
patients
malabsorption
syndromes)
measurement
serum
25(OH)D,
aim
target
concentrations
30
50
ng/mL
(75
125
nmol/L).
Endocrine,
Journal Year:
2022,
Volume and Issue:
79(1), P. 31 - 44
Published: Oct. 26, 2022
This
paper
reports
results
from
the
5th
International
Conference
“Controversies
in
Vitamin
D”
that
was
held
Stresa,
Italy,
15–18
September
2021.
The
conference
is
part
of
this
series
started
2017
and
has
been
conducted
annually
since.
objective
these
conferences
to
identify
timely
controversial
topics
related
D.
Dissemination
through
publications
peer-reviewed
journals
an
important
means
by
which
most
up
date
information
can
be
shared
with
physicians,
investigators,
other
health
care
professionals.
D
aging,
subject
featured
at
conference.
Participants
were
selected
review
available
literature
on
assigned
vitamin
aging
present
their
findings
illustrative
material,
intent
stimulate
discussion
arrive
a
consensus.
presentations
directed
towards
following
areas:
impact
production
levels;
skeletal
effects
deficiency
older
population;
falls
aging;
potential
extra
D;
strategies
prevent
deficiency.
A
final
topic
how
might
influence
efficacy
vaccines
for
Covid-19.
Hypovitaminosis
lead
several
extra-skeletal
outcomes.
Older
adults
are
risk
as
both
metabolism
change
due
factors,
such
reduced
sun
exposure
capacity
skin.
Skeletal
consequences
age-related
changes
include
bone
mineral
density,
osteomalacia
fractures.
Potential
added
risks
falls,
muscle
strength,
diabetes,
cancer,
cardiovascular
disease.
Strategies
avoid
deficiency-related
negative
outcomes
exposure,
food
fortification,
supplementation.
While
does
not
diminish
sufficient
reserve
cutaneous
production,
concerns
about
skin
cancers
practical
matters
institutionalized
elderly
limit
option.
Supplementation
best
option
either
pharmacologically
or
fortification.
Regardless
treatment
strategies,
interventions
restore
status
will
show
positive
only
those
who
truly
deficient.
Thus,
goals
should
focus
avoiding
25(OH)D
serum
levels
<30
nmol/l,
goal
reach
>50
nmol/l.
led
consensus
issues.
supplementation
combined
calcium
reduce
fractures
population.
adequate
level
It
appears
daily
low-dose
regimens
falling,
especially
elderly,
compared
infrequent,
large
bolus
doses
may
increase
it.
role
strength
remains
clarified.
On
hand,
decreases
progression
T2D
prediabetes
among
Ddeficient.
Of
three
possible
establish
sufficiency
–
sunshine
latter
seems
effective
Endocrine Reviews,
Journal Year:
2024,
Volume and Issue:
45(5), P. 625 - 654
Published: April 26, 2024
Abstract
The
6th
International
Conference,
“Controversies
in
Vitamin
D,”
was
convened
to
discuss
controversial
topics,
such
as
vitamin
D
metabolism,
assessment,
actions,
and
supplementation.
Novel
insights
into
mechanisms
of
action
suggest
links
with
conditions
that
do
not
depend
only
on
reduced
solar
exposure
or
diet
intake
can
be
detected
distinctive
noncanonical
metabolites.
Optimal
25-hydroxyvitamin
(25(OH)D)
levels
remain
debated.
Varying
recommendations
from
different
societies
arise
evaluating
clinical
public
health
approaches.
lack
assay
standardization
also
poses
challenges
interpreting
data
available
studies,
hindering
rational
pooling
meta-analyses.
Beyond
the
well-known
skeletal
features,
interest
D's
extraskeletal
effects
has
led
trials
cancer,
cardiovascular
risk,
respiratory
effects,
autoimmune
diseases,
diabetes,
mortality.
initial
negative
results
are
likely
due
enrollment
D-replete
individuals.
Subsequent
post
hoc
analyses
have
suggested,
nevertheless,
potential
benefits
reducing
cancer
incidence,
events,
diabetes.
Oral
administration
is
preferred
route.
Parenteral
reserved
for
specific
situations.
Cholecalciferol
favored
safety
minimal
monitoring
requirements.
Calcifediol
may
used
certain
conditions,
while
calcitriol
should
limited
disorders
which
active
metabolite
readily
produced
vivo.
Further
studies
needed
investigate
relation
recommended
25(OH)D
efficacy
supplementary
formulations
achieving
biochemical
outcomes
within
multifaced
D.
The Journal of Clinical Endocrinology & Metabolism,
Journal Year:
2023,
Volume and Issue:
108(10), P. e1106 - e1116
Published: April 13, 2023
Long
COVID
is
an
emerging
syndrome
affecting
50%
to
70%
of
COVID-19
survivors
that
still
lacks
predicting
factors.Due
the
extraskeletal
effects
vitamin
D,
we
retrospectively
assessed
association
between
25(OH)
D
levels
and
long
in
6
months
after
hospitalization.Long
was
defined
according
NICE
guidelines.
Fifty
50
non-long-COVID
subjects
matched
on
a
1:1
basis
were
enrolled
from
outpatient
clinic
post-COVID
cohort
seen
August
November
2020.
Therapies/comorbidities
calcium/vitamin
D/bone
metabolism,
and/or
admission
intensive
care
unit
during
hospitalization
exclusion
criteria.
Vitamin
measured
at
hospital
discharge.We
observed
lower
levels,
evaluated
follow-up,
with
than
those
without
(20.1
vs
23.2
ng/mL,
P
=
.03).
Regarding
affected
health
areas
entire
cohort,
neurocognitive
symptoms
follow-up
(n
7)
93)
(14.6
20.6
.042).
In
patients
presenting
deficiency
(<20
ng/mL),
both
42),
by
22)
presented
not
20)
(12.7
15.2
.041).
multiple
regression
analyses,
only
variable
significantly
associated
our
(P
.008,
OR
1.09,
CI
1.01-1.16).COVID-19
have
COVID.
Our
data
suggest
should
be
discharge.
The
role
supplementation
as
preventive
strategy
sequelae
tested
randomized
controlled
trials.
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(3), P. 391 - 391
Published: Jan. 29, 2024
Vitamin
D
deficiency
is
considered
a
public
health
problem
due
to
its
worldwide
high
prevalence
and
adverse
clinical
consequences
regarding
musculoskeletal
health.
In
addition,
vitamin
may
also
be
crucial
for
the
prevention
of
certain
extraskeletal
diseases.
Despite
decades
intensive
scientific
research,
several
knowledge
gaps
remain
precise
definition
sufficiency,
benefits
improving
status,
required
intakes.
Consequently,
various
societies
expert
groups
have
released
heterogeneous
recommendations
on
dosages
supplementation.
this
brief
narrative
review,
we
outline
discuss
recent
advances
evidence
arguing
daily
supplementation
with
2000
international
units
(IU)
(50
µg)
D3
prevent
treat
deficiency.
According
data
from
randomized
controlled
trials
(RCTs),
such
dose
improve
some
outcomes
sufficient
raise
maintain
serum
25(OH)D
concentrations
above
50
nmol/L
(20
ng/mL)
75
(30
in
>99%
>90%
general
adult
population,
respectively.
large
RCTs,
there
are
no
significant
safety
concerns
supplementing
years,
even
individuals
an
already
status
at
baseline.
A
IU
simple,
effective,
safe
dosage
population.
Nutrients,
Journal Year:
2022,
Volume and Issue:
14(19), P. 4148 - 4148
Published: Oct. 6, 2022
In
the
recent
years,
both
prescriptions
of
serum
25(OH)D
levels
assay,
and
vitamin
D
supplementation
are
constantly
increasing,
as
well
costs
to
be
incurred
relating
these
specific
aspects.
As
in
many
other
countries,
risk
deficiency
is
particularly
high
Italy,
recently
confirmed
by
cohort
studies
general
population
patients
with
metabolic
bone
disorder.
Results
North-South
gradient
described
among
European
despite
wide
use
supplements.
Although
also
recommended
Italian
Medicine
Agency
for
at
fragility
fracture
or
initiating
osteoporotic
medication,
therapeutic
gap
osteoporosis
Italy
very
high.
There
a
consistent
proportion
not
receiving
therapy
following
fracture,
poor
adherence
recommendations
provided
national
guidelines
position
paper
documents.
The
failure
inadequate
on
antiresorptive
anabolic
treatment
thought
further
amplify
problem
exposes
re-fracture
mortality.
Therefore,
it
important
that
attention
its
possible
clinical
consequences
must
given.
Thus,
light
new
evidence
from
literature,
SIOMMMS
board
felt
need
revise
update,
GRADE/PICO
system
approach,
previous
original
about
definition,
prevention,
adults,
released
2011.
Several
key
points
have
been
here
addressed,
such
definition
status:
normality
values
optimal
values;
who
subjects
considered
hypovitaminosis
D;
opportunity
performing
biochemical
assessment
evaluate
baseline
candidate
pharmacological
osteoporosis;
how
whether
supplement
candidates
active
agents,
population;
chronic
kidney
disease
and/or
liver
diseases
under
drugs
interfering
hepatic
metabolism;
finally,
if
may
toxic
effects
subject
supplementation.
Nutrients,
Journal Year:
2022,
Volume and Issue:
14(9), P. 1816 - 1816
Published: April 26, 2022
Osteosarcopenic
obesity
is
a
unique
clinical
condition
where
low
bone
and
muscle
mass
coexist
in
individuals
with
obesity.
Alterations
adipose
tissue,
skeletal
are
strictly
interconnected,
vitamin
D
plays
key
roles
several
metabolic
pathways
that
involved
maintaining
musculoskeletal
health
glucose
homeostasis.
We
reviewed
the
available
literature
on
mechanisms
underlying
osteosarcopenic
obesity,
focus
role
of
pathogenesis
treatment
condition.
found
that,
although
evidence
from
large
observational
studies
pre-clinical
experiments
strongly
supports
deficiency
common
belief
improves
lacks
solid
evidence,
as
trials
specifically
aimed
at
assessing
effects
supplementation
patients
not
available,
investigated
other
patient
populations
either
showed
no
or
even
detrimental
effects.
conclude
interventional
including
representative
different
sex,
age
race
needed
to
better
define
this
Reviews in Endocrine and Metabolic Disorders,
Journal Year:
2023,
Volume and Issue:
24(6), P. 1011 - 1029
Published: Sept. 4, 2023
Bariatric
surgery
is
associated
with
a
postoperative
reduction
of
25(OH)
vitamin
D
levels
(25(OH)D)
and
skeletal
complications.
Currently,
guidelines
for
25(OH)D
assessment
supplementation
in
bariatric
patients,
pre-
post-surgery,
are
still
lacking.
The
aim
this
work
to
analyse
systematically
the
published
experience
on
status
supplementation,
propose,
basis,
recommendations
management.
Preoperatively,
18
studies
including
2,869
patients
were
evaluated.
Prevalence
insufficiency
as
defined
by
<
30
ng/mL
(75
nmol/L)
was
85%,
whereas
when
20
(50
57%.
median
preoperative
level
19.75
ng/mL.
After
surgery,
39
5,296
analysed
among
those
undergoing
either
malabsorptive
or
restrictive
procedures,
lower
rate
higher
postoperatively
observed
treated
high-dose
oral
≥
2,000
IU/daily
(mostly
D3-formulation),
compared
low-doses
(<
IU/daily).
Our
based
systematic
review
meta-analysis
should
help
clinical
practice
management
before
after
surgery.
Assessment
be
performed
all
Regardless
type
procedure,
recommended